|
Market Closed -
TEL AVIV STOCK EXCHANGE
11:47:02 16/10/2026 BST
|
5-day change | 1st Jan Change | ||
| 2,443.00 ILa | +0.33% |
|
-1.01% | +8.10% |
| 10-06 | Kamada Launches Ustekinumab, Enoxaparin Biosimilars in Israel | MT |
| 10-06 | Kamada Ltd. Announces Expansion of Biosimilars Portfolio with Launch of Two Additional Products in Israel | CI |
Chart: Technical Analysis
TEL AVIV STOCK EXCHANGEILa
| Markets | Quality | ||
|---|---|---|---|
TEL AVIV STOCK EXCHANGE
| KMDA | Delayed | |
Nasdaq
| KMDA | Delayed | |
|
CBOE
| KMDA | Real-time |
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bearish | Bullish | Neutral |
| Resistance | 2,505 | 2,668 | 2,803 |
| Spread/Res. | -2.48% | -8.43% | -12.84% |
| Spread/Supp. | +4.09% | +4.09% | +15.29% |
| Support | 2,347 | 2,347 | 2,119 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- KMDA Stock
- Charts Kamada Ltd.
Select your edition
All financial news and data tailored to specific country editions
